Impact of Neuropsychological Disorders in Multiple Sclerosis (SEVISEP)

Lille Catholic University

Status

Enrolling

Conditions

Multiple Sclerosis

Treatments

Other: Three dimensional gait analysis with eyetracking

Study type

Interventional

Funder types

Other

Identifiers

RC-P00108

Details and patient eligibility

About

The study involves MS patients with and without neuropsychological disorders.

The patient will benefit from:

A routine neuropsychological assessment, including a cognitive and emotional assessment
A clinical examination
A three-dimensional analysis of movement

Enrollment

20 estimated patients

Sex

All

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Understanding and able to speak French
Carriers of MS with relapsing remitting form (RRMS-RR) with an EDSS <4
No significant motor, cerebellar or somesthesia disorders of the upper limbs or visual disturbances (side to a visual EDSS <2)
Absence of corticosteroid intake in the last four weeks
Benefiting from health insurance coverage
Not showing any flare-ups or worsening of the disease in the last 6 weeks
No botulinum toxin injection for more than 4 months

Exclusion criteria

People with previous neurological pathologies, head trauma with loss of consciousness, psychiatric pathologies, serious general ailments, perceptual or dysarthric disorders preventing verbal communication or reading,
Treatment with psychotropic drugs (except benzodiazepines and hypnotics).
Refusal to participate after clear and fair information about the study.
Adults under tutorship, curatorship or safeguard of justice
With orthopedic treatment influencing walking
Pregnant woman